Page 240 - 2019_05-HaematologicaMondo-web

N.S. Majhail et al.
Table 1. Baseline characteristics of patients enrolled on the study. Characteristic
Age at HCT, years; Median (range)
Time from HCT to enrollment (months); Median (range) Age group at baseline survey, years; N (%)
18-29 30-39 40-49 50-59 60-69 ≥70
Gender; N (%)
Male
Female Ethnicity; N (%)
Hispanic/Latino Non-Hispanic/Latino Declined
Race; N (%) White
African-American Asian
Pacific Islander Declined
Diagnosis; N (%)
Acute myeloid leukemia
Acute lymphoblastic leukemia Myelodysplastic/myeloproliferative disorders Chronic myeloid leukemia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Plasma cell disorder/multiple myeloma Other
Time from diagnosis to HCT, months; Median (range)
Year of transplant; N (%) 2010
2011 2012 2013 2014
Transplant type; N (%) Allogeneic Autologous
Donor type; N (%)
Allogeneic, related
Allogeneic, unrelated/umbilical cord blood Autologous
Graft type; N (%) Bone marrow Peripheral blood Umbilical cord blood
SCP (N=231)
59 (19-81)
42 (16-66)
7 (3) 10 (4) 28 (12) 55 (24) 83 (36) 48 (21)
112 (49)
119 (52)
8 (3) 216 (94) 7 (3)
222 (96) 5 (2) 2 (1) 1 (<1) 1 (<1)
52 (23) 10 (4) 19 (8) 2 (1) 13 (6) 49 (21) 78 (34) 8 (3)
7 (1-266)
11 (5) 67 (29) 48 (21) 81 (35) 24 (10)
111 (48) 120 (52)
47 (20) 64 (28) 120 (52)
15 (7) 207 (90) 9 (4)
Routine care (N=227)
59 (20-77)
45 (16-66)
9 (4) 14 (6) 18 (8) 58 (26) 92 (41) 36 (16)
136 (60)
91 (40)
7 (3) 216 (95) 4 (2)
208 (92) 15 (7) 3 (1) 0 (0) 1 (<1)
46 (20) 8 (4) 23 (10) 3 (1) 10 (4) 47 (21) 80 (35) 10 (4) 8 (1- 327)
22 (10) 61 (27) 53 (23) 64 (28) 27 (12)
100 (44) 127 (56)
36 (16) 64 (28) 127 (56)
16 (7) 203 (89) 8 (4)
continued on next page
1086
haematologica | 2019; 104(5)